Denis Guttridge to Neoplasms
This is a "connection" page, showing publications Denis Guttridge has written about Neoplasms.
Connection Strength
2.368
-
Cancer cachexia: involvement of an expanding macroenvironment. Cancer Cell. 2023 03 13; 41(3):581-584.
Score: 0.390
-
Emerging signaling mediators in the anorexia-cachexia syndrome of cancer. Trends Cancer. 2022 05; 8(5):397-403.
Score: 0.364
-
A TGF-? pathway associated with cancer cachexia. Nat Med. 2015 Nov; 21(11):1248-9.
Score: 0.235
-
Impaired regeneration: A role for the muscle microenvironment in cancer cachexia. Semin Cell Dev Biol. 2016 06; 54:82-91.
Score: 0.233
-
Inflammation based regulation of cancer cachexia. Biomed Res Int. 2014; 2014:168407.
Score: 0.212
-
Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 2012 Aug 08; 16(2):153-66.
Score: 0.187
-
Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome. Clin Cancer Res. 2007 Mar 01; 13(5):1356-61.
Score: 0.129
-
Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell. 2005 Nov; 8(5):421-32.
Score: 0.117
-
Extracellular vesicles derived from tumour cells as a trigger of energy crisis in the skeletal muscle. J Cachexia Sarcopenia Muscle. 2022 02; 13(1):481-494.
Score: 0.090
-
Editorial: Highlights from the 2020 virtual cancer cachexia conference. Curr Opin Support Palliat Care. 2021 03 01; 15(1):48-49.
Score: 0.085
-
The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced Cachexia. Cancer Res. 2018 12 01; 78(23):6680-6690.
Score: 0.072
-
Cancer-associated cachexia. Nat Rev Dis Primers. 2018 01 18; 4:17105.
Score: 0.068
-
Ken Fearon. Cell Metab. 2016 12 13; 24(6):765-766.
Score: 0.063
-
Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities. Mol Cancer Ther. 2017 02; 16(2):344-356.
Score: 0.063
-
Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc Natl Acad Sci U S A. 2014 Mar 25; 111(12):4525-9.
Score: 0.052
-
Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J Clin Oncol. 2006 Apr 20; 24(12):1852-9.
Score: 0.008